Filing Details
- Accession Number:
- 0001104659-23-063263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-22 18:51:39
- Reporting Period:
- 2023-05-18
- Accepted Time:
- 2023-05-22 18:51:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600132 | Bellerophon Therapeutics Inc. | BLPH | Pharmaceutical Preparations (2834) | 473116175 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959158 | Bobae Kim | 44 Prospect St. Apt. 536 Morristown NJ 07960 | Vp Reg. Affairs & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-18 | 266 | $7.35 | 1,723 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-05-18 | 1,022 | $7.50 | 1,723 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-18 | 9,455 | $10.00 | 1,723 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2023-05-18 | 266 | $0.00 | 266 | $7.35 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2023-05-18 | 1,022 | $0.00 | 1,022 | $7.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-12-07 | No | 4 | M | Direct | |
| 144 | 2029-09-26 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.26, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The shares subject to this option are fully vested and exercisable.
- This option was granted on September 26, 2019. This option vests in quarterly installments over a four-year period from the date of grant.
Billionaire Hedge Funds
